MetaVia Inc(MTVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MTVA MetaVia Inc

交易中 02-10 10:37:00 EST

1.70

-0.09

-5.03%

最高1.83	最低1.69	成交量7.81万
今开1.83	昨收1.79	日振幅7.82%
总市值545.39万	流通市值389.03万	总股本320.82万
成交额13.47万	换手率3.41%	流通股本228.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":1.7,"timestamp":1770737819717,"preClose":1.79,"halted":0,"volume":78102,"delay":0,"changeRate":-0.05027932960893859,"floatShares":2288400,"shares":3208200,"eps":-11.363935,"marketStatus":"交易中","change":-0.09,"latestTime":"02-10 10:37:00 EST","open":1.83,"high":1.83,"low":1.69,"amount":134695.2246732,"amplitude":0.078212,"askPrice":1.74,"askSize":656,"bidPrice":1.69,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-11.363935,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":1.79,"preHourTrading":{"tag":"盘前","latestPrice":1.8646,"preClose":1.79,"latestTime":"09:12 EST","volume":6623,"amount":12320.1827514,"timestamp":1770732752572,"change":0.0746,"changeRate":0.041676,"amplitude":0.027933},"postHourTrading":{"tag":"盘后","latestPrice":1.84,"preClose":1.79,"latestTime":"19:53 EST","volume":2018,"amount":3705.9576,"timestamp":1770684817009,"change":0.05,"changeRate":0.027933,"amplitude":0.03352},"volumeRatio":1.51301},"requestUrl":"/m/hq/s/MTVA","defaultTab":"news","newsList":[{"id":"1150245570","title":"MetaVia Inc与Syntekabio合作AI建模获突破进展 确认Vanoglipel关键治疗靶点","url":"https://stock-news.laohu8.com/highlight/detail?id=1150245570","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150245570?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:06","pubTimestamp":1770210383,"startTime":"0","endTime":"0","summary":"MetaVia Inc公布其与Syntekabio持续合作中人工智能建模研究的积极成果。最新数据证实，双方共同开发的糖尿病肾病治疗药物Vanoglipel已通过AI模型精准锁定关键治疗靶点。\n这项突破性进展标志着AI驱动药物研发模式在复杂疾病领域的应用迈出重要一步。通过深度学习算法分析海量生物医学数据，研究团队成功验证了Vanoglipel作用于肾脏纤维化与炎症通路的核心机制。\n合作双方表示，该成果将显著加速Vanoglipel的临床前开发进程。AI建模不仅缩短了传统靶点确认周期，更通过多维度模拟预测了化合物与靶点相互作用的特异性，为后续药物优化提供重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"1148649541","title":"MetaVia公布Da-1726代谢疾病一期B临床试验积极结果——显著血糖控制、直接肝脏效应突出、减重效果强劲且安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1148649541","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148649541?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:30","pubTimestamp":1767619821,"startTime":"0","endTime":"0","summary":"MetaVia Inc宣布其针对代谢疾病的候选药物Da-1726在一期B期临床试验中取得具有统计学意义的积极数据。该试验结果显示，Da-1726不仅能有效调控血糖水平，还展现出对肝脏的直接作用机制。此外，受试者在接受治疗后出现显著的体重下降，同时药物整体安全性表现优异，未出现严重不良反应。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"gpt_icon":0},{"id":"2583531690","title":"Metavia Inc.盘中异动 早盘急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583531690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583531690?lang=zh_cn&edition=full","pubTime":"2025-11-12 23:41","pubTimestamp":1762962109,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日23时41分，Metavia Inc.股票出现异动，股价快速下跌5.21%。Metavia Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Leap Therapeutics, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Salarius Pharmaceuticals, Inc.、Leap Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为6158.01%、521.51%、381.17%，振幅较大的相关个股有Leap Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为115.43%、47.96%、47.55%。Metavia Inc.公司简介：MetaVia Inc是一家临床阶段的生物技术公司，专注于开发治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112234149a49cc80f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112234149a49cc80f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","MTVA","OXM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":-0.2251},{"period":"1month","weight":-0.7805},{"period":"3month","weight":-0.7879},{"period":"6month","weight":-0.7457},{"period":"1year","weight":-0.9059},{"period":"ytd","weight":-0.7874}],"compareEarnings":[{"period":"1week","weight":-0.0021},{"period":"1month","weight":-0.0002},{"period":"3month","weight":0.016},{"period":"6month","weight":0.0761},{"period":"1year","weight":0.1551},{"period":"ytd","weight":0.0176}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MetaVia Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目，重点治疗非酒精性脂肪性肝炎（NASH）、肥胖症和2型糖尿病（T2D）。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.000503},{"month":2,"riseRate":0.3,"avgChangeRate":0.018805},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.011768},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.143887},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.109293},{"month":6,"riseRate":0.555556,"avgChangeRate":0.090563},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.026489},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.189997},{"month":9,"riseRate":0.4,"avgChangeRate":0.065402},{"month":10,"riseRate":0.2,"avgChangeRate":-0.186131},{"month":11,"riseRate":0.3,"avgChangeRate":-0.112358},{"month":12,"riseRate":0.1,"avgChangeRate":-0.160075}],"exchange":"NASDAQ","name":"MetaVia Inc","nameEN":"MetaVia Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MetaVia Inc(MTVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MetaVia Inc(MTVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MetaVia Inc,MTVA,MetaVia Inc股票,MetaVia Inc股票老虎,MetaVia Inc股票老虎国际,MetaVia Inc行情,MetaVia Inc股票行情,MetaVia Inc股价,MetaVia Inc股市,MetaVia Inc股票价格,MetaVia Inc股票交易,MetaVia Inc股票购买,MetaVia Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MetaVia Inc(MTVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MetaVia Inc(MTVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}